Physicians Report Expanding Use of Off-Label COVID-19 Treatments
Hydroxychloroquine usage increasing rapidly, although plasma from recovered patients perceived as more effective
Chloroquine COVID-19 Trial Stopped After Patient Deaths
Some patients taking a higher dose developed serious heart rhythm disorders, resulting in 11 deaths
Incident Depression Increases With Body Mass Index
Authors call for antidepressant prescribing, services designed for overweight, obese people
Anxiety Up for Nonmedical Health Care Workers Versus Those on Front Lines
Nonmedical health care workers have higher mean DASS-21 anxiety, stress scores, higher IES-R scores
Face Masks Offer Slight Protective Effect From Flu-Like Illness
Small reduction seen in risk for developing respiratory symptoms from casual exposure in community
Neurologic Effects Seen in a Third of Hospitalized COVID-19 Patients
Manifestations include acute cerebrovascular diseases, impaired consciousness, skeletal muscle injury
Temperature, UV Radiation Not Linked to Incidence of COVID-19
Spread ability of COVID-19 not expected to change with increasing temperature, increasing UV exposure
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...
Clinical Trial Underway to Test Nitric Oxide in COVID-19 Patients
Nitric oxide can improve blood flow in areas of the lungs still receiving air, may have antiviral properties
Suppressing Stomach Acid May Up Intestinal Growth of MDROs
Gastric acid suppression increased odds of intestinal colonization with MDROs by about 75 percent
